InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,346.99
(
-0.11%
)
US TECH 100
18,503.60
(
-0.17%
)
Dow Jones
38,798.99
(
-0.22%
)
Brent Oil
79.34
(
-0.68%
)
Bitcoin
69,045.08
(
-2.43%
)
Post# of 146230
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

FORZANANO

Send PM Follow Ignore
Followers 14
Posts 2928
Boards Moderated 0
Alias Born 09/27/2010

FORZANANO

Re: mike41 post# 95609

Tuesday, 07/29/2014 10:15:53 AM

Tuesday, July 29, 2014 10:15:53 AM

Post# of 146230
mike
I'm sure NNVC continues to test EBOLA, but they are focused on FluCide
at DengueCide. since they have chosen those two drugs to begin with.
But you can look on their website: http://www.nanoviricides.com/pipeline.html

FN
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NNVC News
More NNVC News
InvestorsHub NewsWire

FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM

Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM

Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM

Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM

Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM

IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM

Start posting your company's news
Only $200 per official company press release!